PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $79,000 | +25.4% | 23,201 | -8.6% | 0.00% | – |
| Q2 2017 | $63,000 | +8.6% | 25,387 | 0.0% | 0.00% | – |
| Q1 2017 | $58,000 | -90.8% | 25,387 | -91.5% | 0.00% | -100.0% |
| Q4 2016 | $631,000 | -37.1% | 297,626 | -0.6% | 0.00% | -50.0% |
| Q3 2016 | $1,003,000 | +7.5% | 299,285 | +0.7% | 0.00% | +100.0% |
| Q2 2016 | $933,000 | -6.0% | 297,175 | -0.4% | 0.00% | -50.0% |
| Q1 2016 | $993,000 | -0.4% | 298,243 | +5.9% | 0.00% | +100.0% |
| Q4 2015 | $997,000 | -28.3% | 281,746 | +1.9% | 0.00% | -50.0% |
| Q3 2015 | $1,391,000 | -21.8% | 276,491 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,778,000 | -3.6% | 276,491 | +5.4% | 0.00% | -33.3% |
| Q1 2015 | $1,845,000 | – | 262,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |